Condition: Rare Tumor · Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
A Phase II, open label, non-randomized, multiple-arm, single-center clinical trial in patients with advanced rare solid tumors who failed to standard treatment.
This description comes directly from the study's public registry record.
Ning Li, Doctor · +8601087788713 · lining@cicams.ac.cn
Shuhang Wang, Doctor · +8613581809307 · wangshuhang@cicams.ac.cn
Always discuss trial participation with your own doctor first.
| Cancer hospital Chinese Academy of Medical Sciences | Beijing, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04423185